Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07216144

Centralized Lung Cancer Screening Engagement in At-Risk Populations

Centralized Lung Cancer Screening Engagement in At-Risk Populations (CLEAR)

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
2,000 (estimated)
Sponsor
Weill Medical College of Cornell University · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will assess the impact of centralized outreach on lung cancer screening completion among individuals served by Federally Qualified Health Centers.

Detailed description

This will be a two-arm, parallel, pragmatic randomized controlled trial (RCT) to evaluate the effectiveness of a centralized patient outreach strategy in increasing lung cancer screening (LCS) completion among populations served by Federally Qualified Health Centers (FQHCs). This study will randomize individuals potentially eligible for LCS (50-80 years, current or past smokers) to receive centralized patient outreach in addition to usual care (outreach arm) and usual care alone (usual care arm). Individuals assigned to the outreach arm will receive centralized patient outreach from the Lung screening team through a letter followed by up to three attempts of telephone contact. Individuals assigned to the usual care arm will not receive any contact during the study period and the referral for LCS will be made at the treating physician's discretion.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCentralized patient outreach for lung cancer screeningCentralized patient outreach for lung cancer screening will be conducted by the lung screening team and will consist of a letter followed by telephone contact. One week following the mail invitation, a senior patient coordinator (SPC) will make telephone contact with individuals to pre-screen eligibility determination based on pack-year smoking history. Up to three telephone contact attempts will be made within two weeks.

Timeline

Start date
2025-10-15
Primary completion
2027-02-01
Completion
2027-08-01
First posted
2025-10-14
Last updated
2025-12-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07216144. Inclusion in this directory is not an endorsement.